Bone marrow-derived mesenchymal stem cells for treatment of type 2 diabetes mellitus
This study aims to to improve blood glucose levels in type 2 diabetic patients by transplantation of autologous bone marrow-derived mesenchymal stem cells (BM-MSCs).
Read More
Product Information for
Bone marrow-derived mesenchymal stem cells for treatment of type 2 diabetes mellitus